| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6247047 | Transplantation Proceedings | 2016 | 7 Pages |
Abstract
The requirement for daily maintenance dose was higher in those with CYP3A5*1/*1 variants in both tacrolimus formulations in the Malaysian patients. Furthermore, those with CYP3A5*3/*3 demonstrated significantly higher dose-adjusted Co with Advograf.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
R. Mac Guad, N.L. Zaharan, Z. Chik, Z. Mohamed, N.K. Peng, W.A.H.W.M. Adnan,